Literature DB >> 21279360

[Histopathology of graft-versus-host disease].

F Länger1, F Puls, S Buchholz, C Loddenkemper, A Ganser, H Kreipe.   

Abstract

Graft-versus-host disease (GvHD) occurs as a major complication in 35%-50% of all patients undergoing allogeneic stem cell transplantation. A distinction is made between acute and chronic GvHD depending on the time of onset, type of clinical symptoms and histology. Both forms preferably show manifestations in the skin, mucosal membranes, gastrointestinal tract, liver and (less often) lung. As the clinical presentation is rather unspecific, particularly for the diagnosis of acute GvHD, histology is important to exclude infectious diseases or drug reactions. This review covers the diagnostic morphological criteria and differential diagnoses of GvHD in the skin, gastrointestinal tract and the liver.

Entities:  

Mesh:

Year:  2011        PMID: 21279360     DOI: 10.1007/s00292-010-1408-9

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  29 in total

1.  Gastric graft-versus-host disease: a blinded histologic study.

Authors:  K Washington; R C Bentley; A Green; J Olson; W R Treem; H R Krigman
Journal:  Am J Surg Pathol       Date:  1997-09       Impact factor: 6.394

2.  Mucosal FOXP3+ regulatory T cells are numerically deficient in acute and chronic GvHD.

Authors:  Kathrin Rieger; Christoph Loddenkemper; Jochem Maul; Thomas Fietz; Daniel Wolff; Harald Terpe; Beate Steiner; Erika Berg; Stephan Miehlke; Martin Bornhäuser; Thomas Schneider; Martin Zeitz; Harald Stein; Eckhard Thiel; Rainer Duchmann; Lutz Uharek
Journal:  Blood       Date:  2005-11-08       Impact factor: 22.113

3.  Simultaneous upper and lower endoscopic biopsy in the diagnosis of intestinal graft-versus-host disease.

Authors:  J Roy; D Snover; S Weisdorf; A Mulvahill; A Filipovich; D Weisdorf
Journal:  Transplantation       Date:  1991-03       Impact factor: 4.939

Review 4.  Colonic graft-versus-host disease.

Authors:  William A Ross; Daniel Couriel
Journal:  Curr Opin Gastroenterol       Date:  2005-01       Impact factor: 3.287

5.  Crypt loss is a marker of clinical severity of acute gastrointestinal graft-versus-host disease.

Authors:  Joshua Melson; Shriram Jakate; Henry Fung; Sally Arai; Ali Keshavarzian
Journal:  Am J Hematol       Date:  2007-10       Impact factor: 10.047

6.  Etiology and outcome of diarrhea after marrow transplantation: a prospective study.

Authors:  G J Cox; S M Matsui; R S Lo; M Hinds; R A Bowden; R C Hackman; W G Meyer; M Mori; P I Tarr; L S Oshiro
Journal:  Gastroenterology       Date:  1994-11       Impact factor: 22.682

7.  Initial liver involvement in acute GVHD is predictive for nonrelapse mortality.

Authors:  Marie Robin; Raphael Porcher; Renato de Castro; Gustavo Fisher; Régis Peffault de Latour; Patricia Ribaud; Anna D Petropoulou; Vanderson Rocha; Agnès Devergie; Jean-Yves Mary; Gérard Socié
Journal:  Transplantation       Date:  2009-11-15       Impact factor: 4.939

Review 8.  Diagnosis and manifestations of chronic graft-versus-host disease.

Authors:  Alexandra H Filipovich
Journal:  Best Pract Res Clin Haematol       Date:  2008-06       Impact factor: 3.020

9.  A histopathologic study of gastric and small intestinal graft-versus-host disease following allogeneic bone marrow transplantation.

Authors:  D C Snover; S A Weisdorf; G M Vercellotti; B Rank; S Hutton; P McGlave
Journal:  Hum Pathol       Date:  1985-04       Impact factor: 3.466

Review 10.  Pathology of graft-versus-host disease in the gastrointestinal tract.

Authors:  Kay Washington; Madan Jagasia
Journal:  Hum Pathol       Date:  2009-07       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.